RWDD3 inhibitors represent a class of compounds that specifically interact with and inhibit the function of the RWDD3 protein, also known as RWD domain-containing protein 3. RWDD3 is a member of the RWD protein family, characterized by the presence of a conserved RWD domain, which is implicated in various protein-protein interactions. The RWD domain is involved in key cellular processes, such as ubiquitination, a mechanism that regulates protein stability, activity, and localization within cells. By inhibiting RWDD3, these compounds interfere with the regulatory networks in which RWDD3 participates, particularly in its role as a modulator of protein ubiquitination and possibly in other signaling pathways that involve protein degradation and post-translational modification. Inhibition of RWDD3 can alter the fate of specific proteins targeted for ubiquitination, leading to changes in cellular homeostasis.
Structurally, RWDD3 inhibitors tend to vary widely in terms of their chemical makeup, as the specific interactions between the inhibitor and the RWD domain of RWDD3 can be achieved through different molecular frameworks. These inhibitors may feature distinct functional groups designed to precisely interact with binding pockets or catalytic sites associated with RWDD3's activity. Understanding the structural biology of RWDD3 is critical to the design of effective inhibitors, and much research focuses on mapping its key domains and elucidating how small molecules can disrupt its function. The inhibition of RWDD3, when studied biochemically, provides valuable insights into cellular regulatory mechanisms, and advances in structural analysis allow for the development of highly selective inhibitors that target this specific protein without affecting other members of the RWD family.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
Proteasome inhibitor that can influence protein degradation pathways where RWDD3 may play a role. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
mTOR inhibitor; affects protein synthesis and degradation, potentially impacting RWDD3's cellular role. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
PI3K inhibitor; can influence pathways where RWDD3 may be involved indirectly. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Another PI3K inhibitor that can modulate cellular pathways where RWDD3 might have a role. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
p38 MAPK inhibitor; can affect signaling pathways that might influence RWDD3 activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
MEK inhibitor; impacts the MAPK/ERK pathway which may indirectly affect RWDD3's role. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor; modulation of the JNK pathway might impact processes involving RWDD3. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $61.00 $83.00 $349.00 | 155 | |
NF-kB pathway inhibitor; a potential indirect modulator of processes where RWDD3 might play a role. | ||||||
Z-VAD-FMK | 187389-52-2 | sc-3067 | 500 µg | $74.00 | 256 | |
Pan-caspase inhibitor; by affecting apoptosis, it might influence cellular pathways related to RWDD3. | ||||||
IWP-2 | 686770-61-6 | sc-252928 sc-252928A | 5 mg 25 mg | $94.00 $286.00 | 27 | |
Wnt pathway inhibitor; potential indirect modulation of RWDD3's role. | ||||||